Skip to main content

LifeMD, Inc.

corporate_fare Company Profile

LifeMD, Inc.

LFMD·NASDAQ·Industrial Applications And Services·CIK 0000948320

LifeMD is a patient-centric, direct-to-patient healthcare company that provides virtual medical care and pharmacy services. The company aims to offer a high-quality, cost-effective, and convenient alternative to the traditional healthcare model. LifeMD addresses shortages in U.S. primary care and key specialty areas through a vertically integrated care model. This model combines proprietary technology, affiliated clinical services, pharmacy infrastructure, and AI-enabled operational systems to deliver ongoing care at scale. As of December 31, 2025, LifeMD served approximately 328,000 active patient subscribers. The company provides virtual clinical services and prescription and over-the-counter (OTC) treatments for a range of healthcare needs, including primary care, men's and women's health, hormone health, weight management, insomnia, dermatology, and cardiology. Virtual primary care services are primarily offered through a subscription model. Since its inception, LifeMD has served approximately 1,387,000 patients and customers. Telehealth revenue increased 25% for the year ended December 31, 2025, compared to the year ended December 31, 2024. Approximately 95% of LifeMD's total revenue is derived from recurring subscriptions. The company operates a proprietary, fully integrated telehealth and pharmacy platform that supports diagnosis, treatment, prescription fulfillment, and ongoing care management within a unified ecosystem. This platform is designed to provide cohesive patient experiences for those utilizing LifeMD's affiliated pharmacy.

LifeMD, Inc. (NASDAQ:LFMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for LFMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for LFMD spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • LifeMD Lands Exclusive AT&T Deal: Free Virtual Care for 100M+ Customers
  • LifeMD Misses Q2 Revenue, Slashes 2026 Guidance on GLP-1 Shift
  • LifeMD Forms Exclusive Telehealth Partnership for XYOSTED Testosterone Program
  • LifeMD Lands Exclusive Deal for XYOSTED Testosterone Program, Targeting Millions of Men
  • LifeMD Reports Wider Q1 Loss, Breaches Debt Covenant, Raising Liquidity Concerns

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$194.06M
Net Income
$14.35M
Diluted EPS
$0.25
Op. Cash Flow
$8.28M
Free Cash Flow
$6.41M
Gross Profit
$166.34M
Operating Income
-$7.67M
Cash & Equivalents
$36.79M
Debt / Equity
0.00×
Net Margin
7.4%
Shares Outstanding
46.66M sh
Source: 10-K · filed 2026-03-10 · accession 0001493152-26-009549

Short Interest & Short Volume

7.52 days to cover

FINRA reported short interest of 7,395,023 shares in LFMD as of the September 15, 2026 settlement, a 2.2% increase from the prior period — about 7.5 days to cover at its recent average daily volume. On October 2, 2026, 66.1% of LFMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)7,395,023 shares as of September 15, 2026
Change vs prior period▲ 2.2%
Days to cover7.52 at avg daily volume of 983,396
Daily short volume (FINRA facilities)66.1% of 307,749 shares on October 2, 2026
5-day average short volume65.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for LFMD, detected from its recent SEC filings.

ATM program

Significant Increase in Net Loss · Debt Covenant Breach Reported

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with L →
$2.78 +0.04% today
52-week range · as of 2026-09-15 $2.56 – $7.32
Market cap
$132.07M
Volume
709.1K (0.9× avg)
3-mo avg 762.1K
Live data · 2026-10-05 03:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LFMD - Latest Insights

LFMD
Sep 15, 2026, 10:18 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.30
Real-time Price: $2.78 info
Change: -$0.515 (-16%) info
Market Cap: $132.07M info
LFMD
Aug 05, 2026, 4:56 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.40
Real-time Price: $2.78 info
Change: -$0.620 (-18%) info
Market Cap: $132.07M info
LFMD
Jun 22, 2026, 8:25 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.88
Real-time Price: $2.78 info
Change: -$2.10 (-43%) info
Market Cap: $132.07M info
LFMD
Jun 22, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.88
Real-time Price: $2.78 info
Change: -$2.10 (-43%) info
Market Cap: $132.07M info
LFMD
May 06, 2026, 5:24 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.63
Real-time Price: $2.78 info
Change: -$1.85 (-40%) info
Market Cap: $132.07M info
LFMD
May 06, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.57
Real-time Price: $2.78 info
Change: -$1.79 (-39%) info
Market Cap: $132.07M info
LFMD
May 06, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.60
Real-time Price: $2.78 info
Change: -$1.82 (-40%) info
Market Cap: $132.07M info
LFMD
Apr 10, 2026, 8:15 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.41
Real-time Price: $2.78 info
Change: -$0.630 (-18%) info
Market Cap: $132.07M info
LFMD
Mar 18, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.08
Real-time Price: $2.78 info
Change: -$1.30 (-32%) info
Market Cap: $132.07M info
LFMD
Mar 10, 2026, 4:56 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.82
Real-time Price: $2.78 info
Change: -$1.04 (-27%) info
Market Cap: $132.07M info
LFMD
Mar 09, 2026, 4:37 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $2.78 info
Change: -$0.700 (-20%) info
Market Cap: $132.07M info
LFMD
Mar 09, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $2.78 info
Change: -$0.8204 (-23%) info
Market Cap: $132.07M info
LFMD
Jan 06, 2026, 9:19 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.95
Real-time Price: $2.78 info
Change: -$1.17 (-30%) info
Market Cap: $132.07M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets